Chair's Take on Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
•
1 like•61 views
Brendon Stiles, MD, discusses immunotherapy in earlier stages of lung cancer in this CME/MOC activity titled, "Chair's Take on Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team." For the full presentation, downloadable practice aids, monograph, complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3dtEC0y. CME/MOC credit will be available until June 9, 2021.
